Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Total Current Liabilities: 2019-2025

Historic Total Current Liabilities for Kymera Therapeutics (KYMR) over the last 5 years, with Sep 2025 value amounting to $71.6 million.

  • Kymera Therapeutics' Total Current Liabilities rose 7.58% to $71.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.6 million, marking a year-over-year increase of 7.58%. This contributed to the annual value of $67.8 million for FY2024, which is 20.92% down from last year.
  • Per Kymera Therapeutics' latest filing, its Total Current Liabilities stood at $71.6 million for Q3 2025, which was down 18.24% from $87.5 million recorded in Q2 2025.
  • Kymera Therapeutics' 5-year Total Current Liabilities high stood at $110.1 million for Q1 2021, and its period low was $54.6 million during Q2 2023.
  • In the last 3 years, Kymera Therapeutics' Total Current Liabilities had a median value of $63.2 million in 2023 and averaged $66.9 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first tumbled by 37.60% in 2023, then surged by 40.87% in 2025.
  • Kymera Therapeutics' Total Current Liabilities (Quarterly) stood at $92.5 million in 2021, then declined by 22.91% to $71.3 million in 2022, then rose by 20.11% to $85.7 million in 2023, then decreased by 20.92% to $67.8 million in 2024, then climbed by 7.58% to $71.6 million in 2025.
  • Its Total Current Liabilities stands at $71.6 million for Q3 2025, versus $87.5 million for Q2 2025 and $59.0 million for Q1 2025.